Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CART-EGFRvIII |
Synonyms | |
Therapy Description |
CART-EGFRvIII comprises autologous T-cells engineered with a lentiviral vector to express a chimeric antigen receptor that targets EGFRvIII-expressing tumor cells, which may have anti-tumor activity (PMID: 25696001, PMID: 28724573). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CART-EGFRvIII | CART-EGFRvIII comprises autologous T-cells engineered with a lentiviral vector to express a chimeric antigen receptor that targets EGFRvIII-expressing tumor cells, which may have anti-tumor activity (PMID: 25696001, PMID: 28724573). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|